Time course studies on the functional evaluation of experimental chronic myocardial infarction in rats

By Manikandan Panchatcharam   Sumitra Miriyala   Nayeem Mohammed   Manohar Bhakthavatsalam Murali   Lokanadam Beema   Vairamuthu Subbiah   Subramaniam Samu   Puvanakrishnan Rengarajulu  

Molecular and Cellular Biochemistry, Vol. 267, Iss. 1-2, 2004-12 ,pp. : 47-58

Springer Publishing Company

Access to resources Recommend Favorite

Activation of JNK in the Remote Myocardium after Large Myocardial Infarction in Rats

By Li W.G.   Zaheer A.   Coppey L.   Oskarsson H.J.  

Biochemical and Biophysical Research Communications, Vol. 246, Iss. 3, 1998-05 ,pp. : 816-820

Elsevier

Access to resources Recommend Favorite

Pexelizumab – a C5 complement inhibitor for use in both acute myocardial infarction and cardiac surgery with cardiopulmonary bypass

By Fleisig Ani J   Verrier Edward D  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 6, 2005-06 ,pp. : 833-839

Informa Healthcare

Access to resources Recommend Favorite

Oxidative stress and inflammatory response during and following coronary interventions for acute myocardial infarction

By Berg Kirsti   Jynge Per   Bjerve Kristian   Skarra Sissel   Basu Samar   Wiseth Rune  

Free Radical Research, Vol. 39, Iss. 6, 2005-06 ,pp. : 629-636

Informa Healthcare

Access to resources Recommend Favorite

SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study

By Grammer Tanja   Renner Wilfried   Hoffmann Michael   Kleber Markus   Winkelhofer-Roob Brigitte   Boehm Bernhard   Maerz Winfried  

Free Radical Research, Vol. 43, Iss. 7, 2009-07 ,pp. : 677-684

Informa Healthcare

Access to resources Recommend Favorite